This is the authors' abstract. We don't add key points for this paper.
Vinyl-backbone polymers are commonly used in biomedical applications, but the biodegradability and metabolizability of vinyl backbones have rarely been investigated. We examine the degradation and metabolism of various vinyl-backbone polymers in the presence of chemical oxidants in rat liver microsomes and in human liver cells by using GPC, ATR-FTIR, GC-MS, and LC/MS/MS metabolomic analyses with 13 C-labeled polymers. In biological degradation, only vinyl-backbone polymers with neighboring O or N atoms can be degraded and metabolized into two-carbon-unit molecules, acetic acid or coenzyme A, similar to the fatty acid metabolism, while most vinyl polymers investigated show a certain degree of degradability in chemical degradation. Metabolic profiling of 13 C-labeled polymers reveals that vinyl-backbone polymers with neighboring O or N atoms can be degraded and utilized as fuel molecules or building blocks for the biosynthesis of other metabolites.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: